Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

National Long-Term Follow-up of Children with Sickle Cell Disease Diagnosed By Newborn Screening in the Netherlands: Overview of the Morbidity and Mortality

Caroline Vuong, Cornelia De Groot - Eckhardt, Harriët Heijboer, Monique H. Suijker, Lydian A. De Ligt, Marije Bartels, Paul Brons, Louise Hooimeijer, Eva Rettenbacher, Frans J. Smiers, Marjet A. Stein-Wit, Arian van der Veer, Annemieke Verbaan, Marjon H. Cnossen, Karin Fijnvandraat

Blood (2023) 142 (Supplement 1): 3891.

https://doi.org/10.1182/blood-2023-179802

Published: 2023

Journal Articles

Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16).

Margaret O’Donnell, P Parker, A Dagis, ML Slovak, D Snyder, A Stein, R. Spielberger, A Pawlowska, J Rosenthal, J Palmer, N. Kogut, S. J Forman

Blood (2008) 112 (11): 3286.

https://doi.org/10.1182/blood.V112.11.3286.3286

Published: 2008

Journal Articles

Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia: A Potential Therapeutic Approach for High Risk ALL Patients Not Eligible for Full Intensity Transplantation

A. Stein, J Palmer, M O’Donnell, N. Kogut, R Spielberger, ML Slovak, NC Tsai, S. J Forman

Blood (2008) 112 (11): 4321.

https://doi.org/10.1182/blood.V112.11.4321.4321

Published: 2008

Journal Articles

Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease

Luba Benimetskaya, Sijian Wu, Anatoliy M. Voskresenskiy, Cinara Echart, Jin-Feng Zhou, Joongho Shin, Massimo Iacobelli, Paul Richardson, Kanyalakshmi Ayyanar, C. A. Stein

Blood (2008) 112 (10): 4343–4352.

https://doi.org/10.1182/blood-2008-04-149682

Published: 2008

Journal Articles

Defibrotide (DF), an Orally Bioavailable Modulator of Myeloma Tumor-Microenvironment Interactions: Molecular Sequelae and Clinical Implications.

Constantine S. Mitsiades, Luba Benimetskaya, Krishna Menon, Cinara Echart, Cecile Rouleau, Beverly Teicher, Antonio Palumbo, Mario Boccadoro, Massimo Iacobelli, Kenneth C. Anderson, Cy A. Stein, Paul G. Richardson

Blood (2006) 108 (11): 3523.

https://doi.org/10.1182/blood.V108.11.3523.3523

Published: 2006

Journal Articles

Inhibition of Bcl-2 by Anti-Sense Oligonucleotide and siRNA in Specimens from Patients with Waldenström’s Macroglobulinemia (WM).

Gwen L. Nichols, M.D., Luba Benimetskaya, Ph.D., Cy A. Stein, M.D.Ph.D.

Blood (2004) 104 (11): 2294.

https://doi.org/10.1182/blood.V104.11.2294.2294

Published: 2004

Journal Articles

The mononucleotide-dependent, nonantisense mechanism of action of phosphodiester and phosphorothioate oligonucleotides depends upon the activity of an ecto-5′-nucleotidase

Maria Koziolkiewicz, Edyta Gendaszewska, Maria Maszewska, C. A. Stein, Wojciech J. Stec

Blood (2001) 98 (4): 995–1002.

https://doi.org/10.1182/blood.V98.4.995

Published: 2001

Journal Articles

The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone

A Nademanee, GM Schmidt, P Parker, AC Dagis, A Stein, DS Snyder, M O'Donnell, EP Smith, DE Stepan, A Molina

Blood (1995) 86 (3): 1228–1234.

https://doi.org/10.1182/blood.V86.3.1228.1228

Published: 1995

Journal Articles

High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study [see comments]

A Nademanee, GM Schmidt, MR O'Donnell, DS Snyder, PA Parker, A Stein, E Smith, JA Lipsett, I Sniecinski, K Margolin

Blood (1992) 80 (5): 1130–1134.

https://doi.org/10.1182/blood.V80.5.1130.1130

Published: 1992

NARROW

National Long-Term Follow-up of Children with Sickle Cell Disease Diagnosed By Newborn Screening in the Netherlands: Overview of the Morbidity and Mortality

Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16).

Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia: A Potential Therapeutic Approach for High Risk ALL Patients Not Eligible for Full Intensity Transplantation

Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease

Defibrotide (DF), an Orally Bioavailable Modulator of Myeloma Tumor-Microenvironment Interactions: Molecular Sequelae and Clinical Implications.

Inhibition of Bcl-2 by Anti-Sense Oligonucleotide and siRNA in Specimens from Patients with Waldenström’s Macroglobulinemia (WM).

The mononucleotide-dependent, nonantisense mechanism of action of phosphodiester and phosphorothioate oligonucleotides depends upon the activity of an ecto-5′-nucleotidase

The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone

High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study [see comments]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only